TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32384437

Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (ESWT) - 3 times once per week (n=40)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Corticosteroid injection (CSI) - a single 1-mL dose of betamethasone sodium plus 0.5 mL of prilocaine under ultrasound guidance (n=40)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (ESWT)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Corticosteroid injection (CSI)
Number of subjects: 80
Study: 34315730

Group type: EXPERIMENTAL
Intervention: Peer Navigator Direct Distribution (PND)
Number of subjects: 4163

Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 4163

Group type: COMPARATOR
Intervention: Incentivised Peer Networks (IPN)
Number of subjects: 4163
Study: 33213378

Group type: EXPERIMENTAL
Intervention: 15 mg/day tolvaptan
Number of subjects: 530

Group type: EXPERIMENTAL
Intervention: 7.5 mg/day tolvaptan
Number of subjects: 530

Group type: EXPERIMENTAL
Intervention: Tolvaptan (both dosages)
Number of subjects: 530

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 530
Study: 35581310

Group type: EXPERIMENTAL
Intervention: Morning school timing (07:45 a.m.-12:05 p.m.)
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: Afternoon school timing (12:40 p.m.-05:00 p.m.)
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: Evening school timing (05:20 p.m.-09:40 p.m.)
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: Baseline chronotype
Number of subjects: 259
Study: 32234934

Group type: EXPERIMENTAL
Intervention: Cholecystectomy
Number of subjects: 144

Group type: COMPARATOR
Intervention: No cholecystectomy (Control)
Number of subjects: 144
Study: 35732345

Group type: EXPERIMENTAL
Intervention: Febuxostat
Number of subjects: 6190

Group type: EXPERIMENTAL
Intervention: Allopurinol
Number of subjects: 6190

Group type: COMPARATOR
Intervention: Febuxostat or Allopurinol (discontinuation)
Number of subjects: 6190
Study: 32935453

Group type: EXPERIMENTAL
Intervention: Bacteriostatic saline (0.9% benzyl alcohol)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Buffered 1% lidocaine
Number of subjects: 68
Study: 35564611

Group type: EXPERIMENTAL
Intervention: Short-term intensive-type Cognitive Behavioral Therapy (CBT) intervention
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 43
Study: 33526287

Group type: EXPERIMENTAL
Intervention: Enteral Nutrition (EN)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Parenteral Nutrition (PN)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Low SMI after neoadjuvant chemotherapy
Number of subjects: 87
Study: 34312159

Group type: EXPERIMENTAL
Intervention: 1500 mg calcium propionate (PA)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 32895660

Group type: EXPERIMENTAL
Intervention: Selenium 200 mcg tablets twice daily
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study: 34397746

Group type: EXPERIMENTAL
Intervention: Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) once daily
Number of subjects: 495

Group type: COMPARATOR
Intervention: Stay on baseline regimen (SBR)
Number of subjects: 495
Study: 35076721

Group type: EXPERIMENTAL
Intervention: LSD
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Psilocybin
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Both LSD and Psilocybin
Number of subjects: 142

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 142
Study: 33608814

Group type: EXPERIMENTAL
Intervention: ubrogepant 50 mg
Number of subjects: 2240

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 2240
Study: 34972657

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Regular analgesia
Number of subjects: 120
Study: 32744221

Group type: EXPERIMENTAL
Intervention: Immediate cognitive behavioural therapy (CBT)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Wait-list (WL)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Delayed CBT (after WL)
Number of subjects: 7
Study: 35604034

Group type: EXPERIMENTAL
Intervention: Rural participants
Number of subjects: 2539

Group type: COMPARATOR
Intervention: Urban and suburban participants
Number of subjects: 2539
Study: 34689863

Group type: EXPERIMENTAL
Intervention: High-dose urokinase (50,000 IU injected daily, total 100,000 IU per day)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (20,000 IU injected daily, total 40,000 IU per day)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: High-dose urokinase treatment
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 32807219

Group type: EXPERIMENTAL
Intervention: Robotic-arm assisted unicompartmental knee arthroplasty (RO UKA)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Conventional jig-based unicompartmental knee arthroplasty (CO UKA)
Number of subjects: 140
Study: 36327261

Group type: EXPERIMENTAL
Intervention: Online education and game-based virtual reality phone applications
Number of subjects: 126

Group type: COMPARATOR
Intervention: Traditional education
Number of subjects: 126
Study: 33835822

Group type: EXPERIMENTAL
Intervention: 12-gene GPS assay
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard counseling
Number of subjects: 200
Study: 36411103

Group type: EXPERIMENTAL
Intervention: Standard nail (240 mm)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Long nail
Number of subjects: 182
Study: 32475360

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (1250 µg per week for 2 months)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 36242578

Group type: EXPERIMENTAL
Intervention: Tumor resection
Number of subjects: 101

Group type: COMPARATOR
Intervention: Biopsy
Number of subjects: 101
Study: 32991046

Group type: COMPARATOR
Intervention: L-phenylalanine (10 g)
Number of subjects: 16

Group type: COMPARATOR
Intervention: D-phenylalanine (10 g)
Number of subjects: 16
Study: 32028315

Group type: EXPERIMENTAL
Intervention: Intramedullary nailing
Number of subjects: 240

Group type: COMPARATOR
Intervention: External fixation
Number of subjects: 240
Study: 34798474

Group type: EXPERIMENTAL
Intervention: Body positive content with captions
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Body positive content without captions
Number of subjects: 233

Group type: COMPARATOR
Intervention: Cityscape images (Control)
Number of subjects: 233
Study: 34732661

Group type: EXPERIMENTAL
Intervention: Enhanced recovery after surgery based on pre-operative rehabilitation (group PR-ERAS)
Number of subjects: 213

Group type: COMPARATOR
Intervention: Standardized enhanced recovery after surgery (group S-ERAS)
Number of subjects: 213
Study: 36379593

Group type: EXPERIMENTAL
Intervention: ciKMC
Number of subjects: 4475

Group type: COMPARATOR
Intervention: Control
Number of subjects: 4475
Study: 35717263

Group type: EXPERIMENTAL
Intervention: tranexamic acid
Number of subjects: 0
Study: 35578304

Group type: EXPERIMENTAL
Intervention: Baricitinib 2 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Baricitinib 4 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33069881

Group type: EXPERIMENTAL
Intervention: Ornithine phenylacetate (OP) 10, 15, or 20 g/d
Number of subjects: 231

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 231
Study: 33415852

Group type: EXPERIMENTAL
Intervention: Crossing nape electroacupuncture (EA)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Nape EA
Number of subjects: 160

Group type: COMPARATOR
Intervention: Model group (control)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Normal group (control)
Number of subjects: 160
Study: 35679098

Group type: EXPERIMENTAL
Intervention: Exenatide 2 mg once weekly
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study: 33901056

Group type: EXPERIMENTAL
Intervention: rtfMRI-NF training with functional connectivity information
Number of subjects: 14

Group type: COMPARATOR
Intervention: rtfMRI-NF training using neuronal activity as the neurofeedback signal
Number of subjects: 14
Study: 33112697

Group type: EXPERIMENTAL
Intervention: 1Hz repetitive transcranial magnetic stimulation (rTMS) applied to the right inferior frontal gyrus (rIFG)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Post-hoc comparison of real rTMS first vs. sham first
Number of subjects: 0
Study: 35099356

Group type: EXPERIMENTAL
Intervention: Laparoscopic training
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Robot‐assisted laparoscopic training
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Open surgery training
Number of subjects: 36
Study: 34214867

Group type: EXPERIMENTAL
Intervention: Cerebrolysin (intravenous as add-on therapy)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 0
Study: 35722458

Group type: COMPARATOR
Intervention: Full Range of Motion (fROM) exercises
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Partial Range of Motion (pROM) exercises
Number of subjects: 36
Study: 33840086

Group type: EXPERIMENTAL
Intervention: Holmium LASER resection of the bladder tumor (HoLRBT)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Transurethral resection of bladder tumor (TURBT)
Number of subjects: 88
Study: 35332846

Group type: EXPERIMENTAL
Intervention: Sauna (70°C, 18% RH) for ≤40 min
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Hot-water immersion (HWI) (40°C) for ≤40 min
Number of subjects: 25
Study: 33027046

Group type: EXPERIMENTAL
Intervention: General Anesthesia (GA)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Spinal Anesthesia (SA)
Number of subjects: 40
Study: 36341885

Group type: EXPERIMENTAL
Intervention: Aspirin (75 mg daily)
Number of subjects: 5712

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5712
Study: 34444389

Group type: EXPERIMENTAL
Intervention: Manual suboccipital inhibition technique (MSIT)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Instrumental suboccipital inhibition (INYBI)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Instrumental suboccipital inhibition plus upper cervical manipulation technique (INYBI + UCMT)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 96
Study: 35152509

Group type: EXPERIMENTAL
Intervention: OneShape rotary system (Micro Mega, Besancon, France)
Number of subjects: 164

Group type: COMPARATOR
Intervention: WaveOne Gold reciprocating system (Dentsply Maillefer, Ballaigues, Switzerland)
Number of subjects: 164
Study: 34193961

Group type: EXPERIMENTAL
Intervention: Theta-burst stimulation (TBS) targeting the right and left dorsolateral prefrontal cortex; duration: 6 weeks.
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sham TBS; duration: 6 weeks.
Number of subjects: 100
Study: 32810358

Group type: EXPERIMENTAL
Intervention: Angiotensin II receptor blocker (ARB)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 36561412

Group type: EXPERIMENTAL
Intervention: 20% glycolic acid
Number of subjects: 120

Group type: COMPARATOR
Intervention: 30% salicylic acid
Number of subjects: 120
Study: 35667076

Group type: EXPERIMENTAL
Intervention: Baricitinib plus standard of care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care (placebo)
Number of subjects: 0
Study: 32027547

Group type: EXPERIMENTAL
Intervention: Plasmalyte
Number of subjects: 28

Group type: COMPARATOR
Intervention: Ringer lactate (RL)
Number of subjects: 28
Study: 36646986

Group type: EXPERIMENTAL
Intervention: Ti‐reinforced d‐PTFE membrane
Number of subjects: 40

Group type: COMPARATOR
Intervention: Ti-mesh covered with collagen membrane
Number of subjects: 40
Study: 34088818

Group type: EXPERIMENTAL
Intervention: Multidisciplinary approach (immediate start)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Delayed intervention (6-month delay)
Number of subjects: 111
Study: 35587322

Group type: EXPERIMENTAL
Intervention: Limited adjuvant tamoxifen treatment
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Low-risk classification
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: High-risk classification
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Ultralow-risk classification
Number of subjects: 135
Study: 33847313

Group type: EXPERIMENTAL
Intervention: Bempedoic acid (ETC‐1002)
Number of subjects: 0
Study: 32078609

Group type: EXPERIMENTAL
Intervention: Evidence-based cancer pain management strategies
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Assessment of primary pain characteristics and management of opioid-induced constipation with a bowel regimen
Number of subjects: 64
Study: 34247471

Group type: EXPERIMENTAL
Intervention: Cognitive and motor training (CMT) for visual-motor integration, 6 sessions over 2 weeks
Number of subjects: 63

Group type: COMPARATOR
Intervention: Empty control group (no intervention) for 2 weeks
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Cognitive and motor training (CMT) for visual-motor integration, 6 sessions over 2 weeks (after crossover)
Number of subjects: 63
Study: 34708706

Group type: EXPERIMENTAL
Intervention: Cervical lidocaine spray only
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Oral naproxen only
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Cervical lidocaine spray and naproxen tablet
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 240
Study: 33377367

Group type: EXPERIMENTAL
Intervention: Zinc supplementation (10 mg daily for 4 months)
Number of subjects: 826

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (200,000 IU)
Number of subjects: 826

Group type: EXPERIMENTAL
Intervention: Zinc plus Vitamin A supplementation
Number of subjects: 826

Group type: COMPARATOR
Intervention: Placebo (no zinc, no vitamin A)
Number of subjects: 826
Study: 35263436

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg/day for 120 days
Number of subjects: 30
Study: 32367378

Group type: EXPERIMENTAL
Intervention: Zn-Methionine (Zn-Met)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Zn-Threonine (Zn-Thr)
Number of subjects: 160

Group type: COMPARATOR
Intervention: ZnO 30 mg Zn/kg
Number of subjects: 160

Group type: COMPARATOR
Intervention: ZnO 60 mg Zn/kg
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control diet (30.3 mg Zn/kg diet)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Zn content in egg and excreta
Number of subjects: 160
Study: 36071990

Group type: EXPERIMENTAL
Intervention: Pre-incisional laparoscopic preperitoneal local anesthetic technique (PLPLAT)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 33795116

Group type: EXPERIMENTAL
Intervention: Low-dose everolimus and low-dose tacrolimus (RADTAC group)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard-dose tacrolimus (TAC group)
Number of subjects: 40
Study: 36414368

Group type: EXPERIMENTAL
Intervention: Incentive spirometry (IS)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Deep breathing exercises (DBE)
Number of subjects: 40
Study: 32008286

Group type: EXPERIMENTAL
Intervention: Active tACS (77.5 Hz, 15 mA, 40 minutes/session, 20 sessions over 4 weeks)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham intervention
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Active tACS
Number of subjects: 30

Group type: COMPARATOR
Intervention: Both groups (Active tACS and Sham)
Number of subjects: 30
Study: 35057795

Group type: EXPERIMENTAL
Intervention: Liaison nurse management program
Number of subjects: 80

Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 80
Study: 32314543

Group type: EXPERIMENTAL
Intervention: ABACS (Automatic Body composition Analyser using Computed tomography image Segmentation)
Number of subjects: 5988

Group type: COMPARATOR
Intervention: Manual analysis
Number of subjects: 5988

Group type: EXPERIMENTAL
Intervention: ABACS
Number of subjects: 5988
Study: 35926202

Group type: EXPERIMENTAL
Intervention: Cervical dilators inserted concurrently with misoprostol
Number of subjects: 347

Group type: COMPARATOR
Intervention: Misoprostol alone (control group)
Number of subjects: 347
Study: 34913767

Group type: EXPERIMENTAL
Intervention: Semi‐hepatic alternating radiotherapy (Group A)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Semi‐hepatic sequential radiotherapy (Group B)
Number of subjects: 68
Study: 35278315

Group type: EXPERIMENTAL
Intervention: Headlamp
Number of subjects: 23

Group type: COMPARATOR
Intervention: Night Vision Goggles (NVG)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Night Vision Goggles with Focusing Adaptors (NVG+A)
Number of subjects: 23
Study: 35556932

Group type: EXPERIMENTAL
Intervention: CKD during 0.05Hz maneuver
Number of subjects: 12

Group type: COMPARATOR
Intervention: CON during 0.05Hz maneuver
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: CKD during 0.10Hz maneuver
Number of subjects: 12

Group type: COMPARATOR
Intervention: CON during 0.10Hz maneuver
Number of subjects: 12
Study: 33944876

Group type: EXPERIMENTAL
Intervention: Proactive therapeutic drug monitoring (TDM) with dose and interval adjustments based on scheduled monitoring of serum drug levels and antidrug antibodies (n=207)
Number of subjects: 411

Group type: COMPARATOR
Intervention: Standard infliximab therapy without drug and antibody level monitoring (n=204)
Number of subjects: 411

Group type: EXPERIMENTAL
Intervention: Proactive therapeutic drug monitoring (TDM)
Number of subjects: 411

Group type: COMPARATOR
Intervention: Standard infliximab therapy
Number of subjects: 411
Study: 36326260

Group type: EXPERIMENTAL
Intervention: Infusion of sodium citrate and treprostinil in diluent with magnesium chloride (10 μL/h) with 15 unit-equivalent boluses (150 μL) at 3, 6, and 9 hours after initiation
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Arm infusion site
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Thigh infusion site
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Abdomen infusion site
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Cannula depth (6 mm and 9 mm)
Number of subjects: 40
Study: 35577477

Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 mg
Number of subjects: 3880

Group type: EXPERIMENTAL
Intervention: Tofacitinib 10 mg
Number of subjects: 3880

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3880

Group type: EXPERIMENTAL
Intervention: Tofacitinib (5 mg or 10 mg)
Number of subjects: 3880
Study: 34930228

Group type: EXPERIMENTAL
Intervention: EHR with CDSS
Number of subjects: 5901

Group type: COMPARATOR
Intervention: EHR only
Number of subjects: 5901
Study: 36048114

Group type: EXPERIMENTAL
Intervention: Low-nicotine dose (3% JUUL)/nonpreferred flavor
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Low dose/preferred flavor
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: High-nicotine dose (5% JUUL)/nonpreferred flavor
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: High dose/preferred flavor
Number of subjects: 15
Study: 32290827

Group type: EXPERIMENTAL
Intervention: REACT (including Resource Directory)
Number of subjects: 800

Group type: COMPARATOR
Intervention: Resource Directory only (RD only)
Number of subjects: 800
Study: 36395550

Group type: EXPERIMENTAL
Intervention: beacon‐enhanced tones without alarms
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: tremolo‐enhanced tones without alarms
Number of subjects: 44

Group type: COMPARATOR
Intervention: standard pulse oximetry variable‐pitch tones plus alarms
Number of subjects: 44
Study: 35897493

Group type: EXPERIMENTAL
Intervention: Nature-based meditation
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Indoor meditation
Number of subjects: 68

Group type: COMPARATOR
Intervention: Active control
Number of subjects: 68
Study: 34657218

Group type: EXPERIMENTAL
Intervention: Dapivirine gel
Number of subjects: 26
Study: 32333538

Group type: EXPERIMENTAL
Intervention: Warming needling technique applied to Zusanli (ST36), Sanyinjiao (SP6), and Yinlingquan (SP9) for 30 min before HIPEC, along with intravenous injection of Ondansetron 30 min before HIPEC.
Number of subjects: 120

Group type: COMPARATOR
Intervention: Intravenous injection of Ondansetron 30 min before HIPEC (control group).
Number of subjects: 120
Study: 36097264

Group type: EXPERIMENTAL
Intervention: Moderate intensity exercise (MOD-EX, n=31)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Vigorous intensity exercise (VIG-EX, n=31)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Control group (n=35)
Number of subjects: 145
Study: 33823782

Group type: COMPARATOR
Intervention: Low-Fat Diet
Number of subjects: 42

Group type: COMPARATOR
Intervention: Moderate-Intensity Aerobic Exercise Training (MIAET)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Low-Fat Diet plus MIAET
Number of subjects: 42

Group type: COMPARATOR
Intervention: All groups (including Low-Fat Diet, MIAET, and Low-Fat Diet plus MIAET)
Number of subjects: 42
Study: 32207707

Group type: EXPERIMENTAL
Intervention: Chondroxide magnetophoresis using RPMF (20 mT, frequency 6.25 Hz, exposure time 20 min, No. 12)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo-magnetotherapy of chondroxide
Number of subjects: 65

Group type: COMPARATOR
Intervention: RPMF without local chondroprotective therapy
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Chondroxide magnetophoresis
Number of subjects: 65
Study: 35853131

Group type: EXPERIMENTAL
Intervention: Motivational interviews (MI) - 4 sessions at weekly intervals
Number of subjects: 166

Group type: COMPARATOR
Intervention: Control group - no intervention
Number of subjects: 166
Study: 33844155

Group type: EXPERIMENTAL
Intervention: Ocrelizumab (OCR)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Rituximab (RTX)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Cladribine (CLA)
Number of subjects: 120

Group type: COMPARATOR
Intervention: All groups (OCR, RTX, CLA)
Number of subjects: 120
Study: 34851208

Group type: EXPERIMENTAL
Intervention: DesyncraTM
Number of subjects: 61

Group type: COMPARATOR
Intervention: Cognitive Behavioural Therapy (CBT)
Number of subjects: 61
Study: 32719055

Group type: EXPERIMENTAL
Intervention: As-needed combination preventer and reliever therapy
Number of subjects: 288

Group type: COMPARATOR
Intervention: Maintenance budesonide plus terbutaline reliever therapy
Number of subjects: 288
Study: 36066248

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention with SMART goals set by children over six months.
Number of subjects: 0
Study: 33779212

Group type: EXPERIMENTAL
Intervention: COMPAS program
Number of subjects: 699

Group type: COMPARATOR
Intervention: Waiting-list group (WLG)
Number of subjects: 699